Three messages can all look like “refill problems” while requiring different work:

- A stimulant coverage request is approved, but the pharmacy reports no stock.

- An antipsychotic exception is pending because the plan says it has not received the prescriber’s supporting statement.

- A patient asks for a routine renewal and also reports a significant change in condition.

These are fictional composites, not patient cases. They show why one undifferentiated refill queue is risky: the blocker, owner, next action, clock, and escalation route are not the same.

> A medication-access request should never sit in a queue without a category, an owner, a next action, a source-based follow-up trigger, and a defined final-resolution condition.

## Start with the blocker, not the message label

“Refill delayed” may mean the practice has not made a prescription decision; a payer needs a prior authorization, exception, or more information; a payer issued a denial; a pharmacy has a stock, ordering, validity, partial-fill, or transfer problem; the patient has not received the latest status; or new clinical information means the request no longer belongs in a routine administrative queue.

Classification comes first because it determines who can act. A payer cannot resolve pharmacy stock. A pharmacy cannot decide whether the practice will issue a prescription. An administrative coordinator should not attempt to resolve a potential clinical deterioration.

## The ownership map

This is an adaptable control, not a universal legal checklist. Local roles, state law, payer rules, medication-specific processes, and practice policy still govern.

Blocker

Internal owner

Outside actor

Next action

Clock source

Current lane is complete when

Prescription decision needed

Prescriber or designated clinical-queue owner

None

Review under practice policy; issue, decline, or route for clinical follow-up

Clinical need and practice policy

The prescription decision is documented and communicated, or clinical follow-up is transferred to a receiving owner with a next action and follow-up trigger

Prior authorization or exception pending

PA coordinator or designated operations owner

Payer or pharmacy benefit manager (PBM)

Confirm receipt, request type, missing requirements, and current submission route

Current portal, notice, plan document, contract, or applicable rule

The determination is received and communicated; if another action is required, the receiving owner and follow-up trigger are recorded

Pharmacy reports no stock or another dispensing barrier

Medication-access staff or designated queue owner

Pharmacy

Confirm the specific barrier and identify the permitted next route without promising availability

Pharmacy response plus applicable prescribing and pharmacy requirements

The specific pharmacy task is completed, or the unresolved barrier is transferred to a receiving owner with the next action and follow-up trigger documented

Denial received

PA coordinator with prescriber involvement when needed

Payer or PBM

Review the denial and decide whether to pursue an appeal, exception, alternative, or no further administrative action

Denial notice and applicable plan process

The denial is reviewed and the request is either formally concluded or transferred to a receiving owner for an appeal, exception, alternative, or clinical decision, with the next action and follow-up trigger documented

Patient reports deterioration or a potential safety concern

Clinical-triage owner

Patient, prescriber, or emergency resource as appropriate

Remove from the routine queue and follow the practice’s established clinical-triage or emergency process

Practice clinical-escalation policy and the patient’s current presentation

A qualified clinical disposition is documented and any further action is assigned to a receiving owner with a follow-up trigger under practice policy

Completing one lane does not close the overall request when dispensing, clinical review, an appeal, or another action remains pending. Keep the receiving owner and follow-up trigger visible until the request is resolved or formally concluded.

Download: Psychiatric Medication-Access Ownership Map (PDF, one page).

## “Sent to the payer” names an action, not an owner

It does not identify who will confirm receipt, watch the response, catch a missed step, or tell the patient what happened.

Every unresolved item should show:

- the current internal owner

- the action already completed

- the person or organization expected to respond

- the source that sets the next follow-up time

- the next follow-up date or event trigger

- the backup escalation route

- the condition that will establish final resolution or formal conclusion

Ownership may change as the request moves. It should never become blank.

## Pull it off the routine queue when the facts change

Define prompts for administrative staff to stop routine processing and route the message to the practice’s clinical process. Depending on the practice, those prompts may include:

- reported suicidal thinking, psychosis, manic symptoms, severe withdrawal concerns, or acute deterioration

- a medication interruption that may create a clinically significant risk

- a report that the medication is being taken differently from the prescription

- a new pharmacy or payer message that raises a safety or prescribing-validity concern

- uncertainty about whether the problem is administrative or clinical

These are routing prompts, not diagnostic criteria. Nonclinical staff should not be asked to make a clinical disposition.

## The clock is not one number

Federal examples below were reviewed as of July 26, 2026. Regulatory timeframes belong to defined programs and request types. They are not promises of approval, dispensing, or access.

Medicare Part D. For a drug-benefit coverage determination, the current federal rule generally requires the plan sponsor to notify the enrollee no later than 72 hours after receiving a standard request. If the request is an exception, the prescriber’s supporting statement changes the clock. If the plan approves expedited handling, the determination and notice generally are due no later than 24 hours after receipt; exception requests again have a supporting-statement rule.

Medicaid. Staff must distinguish a service authorization from a covered-outpatient-drug authorization. For rating periods beginning on or after January 1, 2026, the general Medicaid managed-care rule sets a state-established standard service-authorization timeframe that may not exceed seven calendar days after receipt, and a conditional expedited service process with a 72-hour outer limit, subject to specified extensions. Those general service deadlines do not govern all covered-outpatient-drug decisions. The regulation separately directs drug authorization decisions to the Medicaid covered-outpatient-drug statute. That statute, within its stated scope and qualifications, requires a response by telephone or another telecommunications device within 24 hours of a prior-authorization request and provides for at least a 72-hour supply in an emergency situation. State implementation and drug-specific procedures still require verification.

Record the current program, request type, completeness or supporting-statement rule, authoritative source, and follow-up trigger. Do not memorize a single deadline.

## Keep payer and pharmacy as separate lanes

A favorable payer determination does not establish that a pharmacy has stock or can lawfully dispense the prescription.

- Payer lane: request type, current route, confirmation or reference number if issued, requested support, determination or notice, and appeal or exception path.

- Pharmacy lane: pharmacy contacted, stated stock or ordering status, prescription issue, transfer or partial-fill question, response, and unresolved escalation.

The team should be able to see where the request stopped. One organization’s action is not proof that the next organization is ready.

## Send what the request needs

Confirm the current payer request before assembling support. For disclosures subject to HIPAA’s minimum-necessary standard, limit what is disclosed to what is reasonably necessary for the purpose. An entire medical record requires specific justification when that standard applies.

HIPAA includes exceptions, including provider-to-provider treatment disclosures. A payer-facing payment or coverage workflow should not be assumed to be one. Follow the practice’s approved privacy process, and get qualified guidance when the situation is uncertain.

The federal sources reviewed for this article do not establish one universal list of required fields for every psychiatric refill or prior authorization.

## Give the patient a status, not a prediction

A staff update can answer six questions without promising an outcome:

1. What did the practice receive?

2. What action did the practice complete?

3. Who is expected to act next?

4. Is anything else needed?

5. When will the practice check again?

6. Which practice-approved route should the patient use if the situation changes or becomes urgent?

Do not guarantee approval, expedited eligibility, pharmacy stock, or a dispensing date.

Download: Medication-Access Status Update Script (PDF, one page).

## Closed loop until the condition is met

Submission is not resolution. Distinguish whether the current task is complete, the request has a new owner, an unresolved request is still being watched, or the overall request has reached final resolution or formal conclusion.

Record the overall request as resolved or formally concluded only when the stated condition is met and no action or expected response remains pending. Completing a task or transferring ownership is control. It is not, by itself, resolution.

Four questions are enough:

> Who owns the next action? What is the next action? What source sets the follow-up time? What will establish final resolution or formal conclusion?

That is the ownership map. It turns “refill delayed” into visible work without pretending that one checklist, one deadline, or one electronic system applies to every patient, plan, pharmacy, and state.

---

## Sources

- Electronic Code of Federal Regulations, 42 C.F.R. § 423.568 — Standard Medicare Part D coverage-determination timeframes, reviewed July 26, 2026.

- Electronic Code of Federal Regulations, 42 C.F.R. § 423.572 — Expedited Medicare Part D coverage-determination timeframes, reviewed July 26, 2026.

- Electronic Code of Federal Regulations, 42 C.F.R. § 438.210 — Medicaid managed-care coverage and authorization of services, reviewed July 26, 2026.

- U.S. Government Publishing Office, 42 U.S.C. § 1396r-8(d)(5) — Medicaid covered-outpatient-drug prior-authorization programs, reviewed July 26, 2026.

- Electronic Code of Federal Regulations, 45 C.F.R. § 164.502(b) — HIPAA minimum-necessary standard and exceptions, reviewed July 26, 2026.

- Electronic Code of Federal Regulations, 45 C.F.R. § 164.514(d) — HIPAA minimum-necessary implementation requirements, reviewed July 26, 2026.

General educational information for U.S. psychiatric practice operations. Not legal, billing, compliance, or clinical advice. Verify current requirements with the applicable authoritative source.